Javad Aminian-Dehkordi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Javad Aminian-Dehkordi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Reza Kaazempur Mofrad
University of California
8 shared publications - Amin Valiei
Department of Chemical Engineering, McGill University, Montreal, Quebec H3A 0C5, Canada
2 shared publications - Mohammad Parsa
University of California, Berkeley
2 shared publications Amin Valiei
Molecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California
1 shared publicationAndrew Dickson
Molecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California, Berkeley, USA
1 shared publication- Andrew Dickson
Molecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California
1 shared publication
Latest Publications
- Open Access
Decision-relevant measurement for precision microbiome interventions
Human gut microbiome studies often rely on stool, despite increasing evidence that it incompletely represents the spatially heterogeneous intestinal ecosystem. Whether this loss of spatial detail matters for downstream intervention decisions is largely unresolved. We treat compositional reconstruction and decision preservation as separate objectives. Using 16 matched recovery events from 11 participants, each containing stool and four intended regional capsule measurements, we aggregated amplicon sequence variants into 11 prespecified taxonomic–functional proxy guilds. We evaluated regional-to-stool models by nested leave-one-participant-out validation under complementary compositional geometries. We then assessed decision preservation through three spatial proxy states and measurement-induced decision loss (MIDL) across normalized binary intervention thresholds. Multi-region CLR ridge and Aitchison regional-plus-reference models had the lowest point-estimate Aitchison errors, but evidence that either outperformed the population Aitchison center was not retained after multiplicity correction. Rankings changed under total variation and after guild amalgamation; at the coarser resolution, the primary ordering showed a small, uncertain reversal that was sensitive to zero handling. The model with the lowest compositional error did not have the lowest MIDL-curve calibration error. Population centers closely reproduced the nearly uninformative observed-stool MIDL curves while retaining little individualized regional information. These findings show that reconstruction, decision preservation, and calibration to observed-stool decision loss answer different questions. Evaluation of microbiome measurement strategies should therefore treat compositional geometry, biological representation, and the downstream decision task as parts of the estimand.
Open AccessDecision-relevant measurement for precision microbiome interventions
Human gut microbiome studies often rely on stool, despite increasing evidence that it incompletely represents the spatially heterogeneous intestinal ecosystem. Whether this loss of spatial detail matters for downstream intervention decisions is largely unresolved. We treat compositional reconstruction and decision preservation as separate objectives. Using 16 matched recovery events from 11 participants, each containing stool and four intended regional capsule measurements, we aggregated amplicon sequence variants into 11 prespecified taxonomic–functional proxy guilds. We evaluated regional-to-stool models by nested leave-one-participant-out validation under complementary compositional geometries. We then assessed decision preservation through three spatial proxy states and measurement-induced decision loss (MIDL) across normalized binary intervention thresholds. Multi-region CLR ridge and Aitchison regional-plus-reference models had the lowest point-estimate Aitchison errors, but evidence that either outperformed the population Aitchison center was not retained after multiplicity correction. Rankings changed under total variation and after guild amalgamation; at the coarser resolution, the primary ordering showed a small, uncertain reversal that was sensitive to zero handling. The model with the lowest compositional error did not have the lowest MIDL-curve calibration error. Population centers closely reproduced the nearly uninformative observed-stool MIDL curves while retaining little individualized regional information. These findings show that reconstruction, decision preservation, and calibration to observed-stool decision loss answer different questions. Evaluation of microbiome measurement strategies should therefore treat compositional geometry, biological representation, and the downstream decision task as parts of the estimand.
- Open Access
Measurement-Induced Decision Loss: A feasible-set theory of microbiome intervention under observation loss
Microbiome measurements are commonly judged by how faithfully they reconstruct an underlying biological profile, using taxonomic similarity, prediction accuracy, or compositional distance. Yet faithfulness and usefulness are not the same: a distorted measurement may still support the correct intervention, while a small error can be decisive when it falls near the boundary between two treatment choices. We therefore evaluate measurement quality by whether information loss changes the decisions and outcomes that remain attainable. We treat the intervention-relevant state of the gut community as a hidden quantity seen only through an imperfect, information-losing measurement, mapped by a decision rule to a graded intervention. Each decision rule is evaluated by net host benefit and ecological margin, generating a feasible set of attainable outcome pairs. We define the measurement-induced decision loss (MIDL) as the maximum net host benefit lost under imperfect measurement relative to perfect observation. For scalar affine information loss, increasing degradation is a Blackwell garbling; under post-processing closure, more informative measurement weakly expands the feasible set and cannot reduce optimal host benefit. In the binary-state model, MIDL increases linearly while an observation-dependent decision rule remains optimal and plateaus once the optimal policy becomes signal-independent. We extend the framework to finite states, state-specific loss, multi-segment stool aggregation, and ecological-margin constraints. The framework distinguishes measurement faithfulness from decision usefulness and provides a principled basis for comparing stool and richer measurements by the interventions and trade-offs they support.
Open AccessMeasurement-Induced Decision Loss: A feasible-set theory of microbiome intervention under observation loss
Microbiome measurements are commonly judged by how faithfully they reconstruct an underlying biological profile, using taxonomic similarity, prediction accuracy, or compositional distance. Yet faithfulness and usefulness are not the same: a distorted measurement may still support the correct intervention, while a small error can be decisive when it falls near the boundary between two treatment choices. We therefore evaluate measurement quality by whether information loss changes the decisions and outcomes that remain attainable. We treat the intervention-relevant state of the gut community as a hidden quantity seen only through an imperfect, information-losing measurement, mapped by a decision rule to a graded intervention. Each decision rule is evaluated by net host benefit and ecological margin, generating a feasible set of attainable outcome pairs. We define the measurement-induced decision loss (MIDL) as the maximum net host benefit lost under imperfect measurement relative to perfect observation. For scalar affine information loss, increasing degradation is a Blackwell garbling; under post-processing closure, more informative measurement weakly expands the feasible set and cannot reduce optimal host benefit. In the binary-state model, MIDL increases linearly while an observation-dependent decision rule remains optimal and plateaus once the optimal policy becomes signal-independent. We extend the framework to finite states, state-specific loss, multi-segment stool aggregation, and ecological-margin constraints. The framework distinguishes measurement faithfulness from decision usefulness and provides a principled basis for comparing stool and richer measurements by the interventions and trade-offs they support.
- Open Access
Identifiability limits of metabolic dynamics from sparse longitudinal metabolomics
Sparse and irregular longitudinal metabolomic measurements can make dynamical quantities numerically estimable without making them scientifically identifiable. We formulate effective-landscape inference as an observation-timescale inverse problem and evaluate its operating characteristics using stochastic systems with known ground truth and longitudinal stool metabolomics from the Integrative Human Microbiome Project. Across simulation ensembles, recovery of a known double-well topology declined sharply as observations became sparse, whereas the tested monostable controls did not generate spurious secondary minima. Findings establish an identifiability hierarchy: global topology requires sufficient within-subject state-space coverage, whereas local return descriptors remain vulnerable to bias from the observation process. The framework therefore shifts the emphasis from assigning stability labels to determining what a sampling design can support. It provides a basis for designing denser longitudinal experiments and for validating clinical and machine-learning studies in which sparse observations might otherwise be overinterpreted as evidence about underlying dynamics.
Open AccessIdentifiability limits of metabolic dynamics from sparse longitudinal metabolomics
Sparse and irregular longitudinal metabolomic measurements can make dynamical quantities numerically estimable without making them scientifically identifiable. We formulate effective-landscape inference as an observation-timescale inverse problem and evaluate its operating characteristics using stochastic systems with known ground truth and longitudinal stool metabolomics from the Integrative Human Microbiome Project. Across simulation ensembles, recovery of a known double-well topology declined sharply as observations became sparse, whereas the tested monostable controls did not generate spurious secondary minima. Findings establish an identifiability hierarchy: global topology requires sufficient within-subject state-space coverage, whereas local return descriptors remain vulnerable to bias from the observation process. The framework therefore shifts the emphasis from assigning stability labels to determining what a sampling design can support. It provides a basis for designing denser longitudinal experiments and for validating clinical and machine-learning studies in which sparse observations might otherwise be overinterpreted as evidence about underlying dynamics.
- Open Access
KODA: An Agentic Framework for KEGG Orthology-Driven Discovery of Antimicrobial Drug Targets in Gut Microbiome
The gut microbiome plays a crucial role in human health and disease, influencing diverse biological processes such as immune regulation and nutrient metabolism. However, the complexity of micro-bial interactions and their metabolic cross-feeding dynamics remains poorly understood. This study proposes KODA, an agentic framework that integrates large language models (LLMs) and knowledge graphs (KGs) to facilitate the discovery of targets in antimicrobial drugs in the gut microbiome. Our approach employs a multi-agent system to interpret natural language queries and translate them into precise graph database queries, enabling intuitive interactions with complex microbiome data. Focusing on KEGG orthologies related to essential microbial genes, KODA identifies potential antimicrobial drug targets by analyzing microbial metabolic pathways. The system employs a Neo4j-based microbiome KG, which integrates microbial interaction data, metabolic models, and KEGG annotations. A dedicated evaluation framework, which incorporates LLM-based reviewers, assesses the quality of generated queries and analytical reports. Our results demonstrate the efficacy of KODA in providing actionable insights for antimicrobial research, particularly in identifying conserved essential genes as potential drug targets. This framework holds the potential to democratize microbiome research by lowering technical barriers and accelerating hypothesis generation in drug discovery.
Open AccessKODA: An Agentic Framework for KEGG Orthology-Driven Discovery of Antimicrobial Drug Targets in Gut Microbiome
The gut microbiome plays a crucial role in human health and disease, influencing diverse biological processes such as immune regulation and nutrient metabolism. However, the complexity of micro-bial interactions and their metabolic cross-feeding dynamics remains poorly understood. This study proposes KODA, an agentic framework that integrates large language models (LLMs) and knowledge graphs (KGs) to facilitate the discovery of targets in antimicrobial drugs in the gut microbiome. Our approach employs a multi-agent system to interpret natural language queries and translate them into precise graph database queries, enabling intuitive interactions with complex microbiome data. Focusing on KEGG orthologies related to essential microbial genes, KODA identifies potential antimicrobial drug targets by analyzing microbial metabolic pathways. The system employs a Neo4j-based microbiome KG, which integrates microbial interaction data, metabolic models, and KEGG annotations. A dedicated evaluation framework, which incorporates LLM-based reviewers, assesses the quality of generated queries and analytical reports. Our results demonstrate the efficacy of KODA in providing actionable insights for antimicrobial research, particularly in identifying conserved essential genes as potential drug targets. This framework holds the potential to democratize microbiome research by lowering technical barriers and accelerating hypothesis generation in drug discovery.
- Open Access
SIMBA-GNN: Simulation-augmented Microbiome Abundance Graph Neural Network
Understanding gut microbiome dynamics gut requires deciphering complex, metabolically driven interactions beyond taxonomic profiles. We present SIMBA , a novel framework that integrates mechanistic metabolic simulations with a graph neural network (GNN) to predict microbial abundances and uncover cross-feeding relationships. By simulating pairwise interactions among gut microbes using metabolic networks, we generate biologically grounded graphs that capture metabolite cross-feeding and functional relationships. Our custom GNN, enhanced with edge-aware attention, is trained through a multi-stage pipeline combining self-supervised learning, simulation-based pretraining, and fine-tuning on real microbial abundance data. SIMBA achieves state-of-the-art performance (Spearman ρ = 0.85) and enables interpretable insights into keystone taxa and metabolic bottlenecks. This work demonstrates the power of combining metabolic networks with deep learning for precision microbiome analysis.
Open AccessSIMBA-GNN: Simulation-augmented Microbiome Abundance Graph Neural Network
Understanding gut microbiome dynamics gut requires deciphering complex, metabolically driven interactions beyond taxonomic profiles. We present SIMBA , a novel framework that integrates mechanistic metabolic simulations with a graph neural network (GNN) to predict microbial abundances and uncover cross-feeding relationships. By simulating pairwise interactions among gut microbes using metabolic networks, we generate biologically grounded graphs that capture metabolite cross-feeding and functional relationships. Our custom GNN, enhanced with edge-aware attention, is trained through a multi-stage pipeline combining self-supervised learning, simulation-based pretraining, and fine-tuning on real microbial abundance data. SIMBA achieves state-of-the-art performance (Spearman ρ = 0.85) and enables interpretable insights into keystone taxa and metabolic bottlenecks. This work demonstrates the power of combining metabolic networks with deep learning for precision microbiome analysis.
- Open Access
- 20 May 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (5) , e0165224
Meta Biome: a multiscale model integrating agent-based and metabolic networks to reveal spatial regulation in gut mucosal microbial communities
Mucosal microbial communities (MMCs) are complex ecosystems near the mucosal layers of the gut essential for maintaining health and modulating disease states. Despite advances in high-throughput omics technologies, current methodologies struggle to capture the dynamic metabolic interactions and spatiotemporal variations within MMCs. In this work, we present Meta Biome, a multiscale model integrating agent-based modeling (ABM), finite volume methods, and constraint-based models to explore the metabolic interactions within these communities. Integrating ABM allows for the detailed representation of individual microbial agents each governed by rules that dictate cell growth, division, and interactions with their surroundings. Through a layered approach—encompassing microenvironmental conditions, agent information, and metabolic pathways—we simulated different communities to showcase the potential of the model. Using our in-silico platform, we explored the dynamics and spatiotemporal patterns of MMCs in the proximal small intestine and the cecum, simulating the physiological conditions of the two gut regions. Our findings revealed how specific microbes adapt their metabolic processes based on substrate availability and local environmental conditions, shedding light on spatial metabolite regulation and informing targeted therapies for localized gut diseases. Meta Biome provides a detailed representation of microbial agents and their interactions, surpassing the limitations of traditional grid-based systems. This work marks a significant advancement in microbial ecology, as it offers new insights into predicting and analyzing microbial communities. IMPORTANCE: Our study presents a novel multiscale model that combines agent-based modeling, finite volume methods, and genome-scale metabolic models to simulate the complex dynamics of mucosal microbial communities in the gut. This integrated approach allows us to capture spatial and temporal variations in microbial interactions and metabolism that are difficult to study experimentally. Key findings from our model include the following: (i) prediction of metabolic cross-feeding and spatial organization in multi-species communities, (ii) insights into how oxygen gradients and nutrient availability shape community composition in different gut regions, and (iii) identification of spatiallyregulated metabolic pathways and enzymes in E. coli . We believe this work represents a significant advance in computational modeling of microbial communities and provides new insights into the spatial regulation of gut microbiome metabolism. The multiscale modeling approach we have developed could be broadly applicable for studying other complex microbial ecosystems.
- 20 May 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (5) , e0165224
Open AccessMeta Biome: a multiscale model integrating agent-based and metabolic networks to reveal spatial regulation in gut mucosal microbial communities
Mucosal microbial communities (MMCs) are complex ecosystems near the mucosal layers of the gut essential for maintaining health and modulating disease states. Despite advances in high-throughput omics technologies, current methodologies struggle to capture the dynamic metabolic interactions and spatiotemporal variations within MMCs. In this work, we present Meta Biome, a multiscale model integrating agent-based modeling (ABM), finite volume methods, and constraint-based models to explore the metabolic interactions within these communities. Integrating ABM allows for the detailed representation of individual microbial agents each governed by rules that dictate cell growth, division, and interactions with their surroundings. Through a layered approach—encompassing microenvironmental conditions, agent information, and metabolic pathways—we simulated different communities to showcase the potential of the model. Using our in-silico platform, we explored the dynamics and spatiotemporal patterns of MMCs in the proximal small intestine and the cecum, simulating the physiological conditions of the two gut regions. Our findings revealed how specific microbes adapt their metabolic processes based on substrate availability and local environmental conditions, shedding light on spatial metabolite regulation and informing targeted therapies for localized gut diseases. Meta Biome provides a detailed representation of microbial agents and their interactions, surpassing the limitations of traditional grid-based systems. This work marks a significant advancement in microbial ecology, as it offers new insights into predicting and analyzing microbial communities. IMPORTANCE: Our study presents a novel multiscale model that combines agent-based modeling, finite volume methods, and genome-scale metabolic models to simulate the complex dynamics of mucosal microbial communities in the gut. This integrated approach allows us to capture spatial and temporal variations in microbial interactions and metabolism that are difficult to study experimentally. Key findings from our model include the following: (i) prediction of metabolic cross-feeding and spatial organization in multi-species communities, (ii) insights into how oxygen gradients and nutrient availability shape community composition in different gut regions, and (iii) identification of spatiallyregulated metabolic pathways and enzymes in E. coli . We believe this work represents a significant advance in computational modeling of microbial communities and provides new insights into the spatial regulation of gut microbiome metabolism. The multiscale modeling approach we have developed could be broadly applicable for studying other complex microbial ecosystems.
- Open Access
- 2 October 2024
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 10 (1) , 1-13
Metabolic interactions shape emergent biofilm structures in a conceptual model of gut mucosal bacterial communities
The gut microbiome plays a major role in human health; however, little is known about the structural arrangement of microbes and factors governing their distribution. In this work, we present an in silico agent-based model (ABM) to conceptually simulate the dynamics of gut mucosal bacterial communities. We explored how various types of metabolic interactions, including competition, neutralism, commensalism, and mutualism, affect community structure, through nutrient consumption and metabolite exchange. Results showed that, across scenarios with different initial species abundances, cross-feeding promotes species coexistence. Morphologically, competition and neutralism resulted in segregation, while mutualism and commensalism fostered high intermixing. In addition, cooperative relations resulted in community properties with little sensitivity to the selective uptake of metabolites produced by the host. Moreover, metabolic interactions strongly influenced colonization success following the invasion of newcomer species. These results provide important insights into the utility of ABM in deciphering complex microbiome patterns.
- 2 October 2024
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 10 (1) , 1-13
Open AccessMetabolic interactions shape emergent biofilm structures in a conceptual model of gut mucosal bacterial communities
The gut microbiome plays a major role in human health; however, little is known about the structural arrangement of microbes and factors governing their distribution. In this work, we present an in silico agent-based model (ABM) to conceptually simulate the dynamics of gut mucosal bacterial communities. We explored how various types of metabolic interactions, including competition, neutralism, commensalism, and mutualism, affect community structure, through nutrient consumption and metabolite exchange. Results showed that, across scenarios with different initial species abundances, cross-feeding promotes species coexistence. Morphologically, competition and neutralism resulted in segregation, while mutualism and commensalism fostered high intermixing. In addition, cooperative relations resulted in community properties with little sensitivity to the selective uptake of metabolites produced by the host. Moreover, metabolic interactions strongly influenced colonization success following the invasion of newcomer species. These results provide important insights into the utility of ABM in deciphering complex microbiome patterns.
- Top Cited PapersOpen Access
- 28 February 2023
- Published by AIP Publishing in APL Bioengineering
- Vol. 7 (1) , 011502
Gut-on-a-chip models for dissecting the gut microbiology and physiology
Microfluidic technologies have been extensively investigated in recent years for developing organ-on-a-chip-devices as robust in vitro models aiming to recapitulate organ 3D topography and its physicochemical cues. Among these attempts, an important research front has focused on simulating the physiology of the gut, an organ with a distinct cellular composition featuring a plethora of microbial and human cells that mutually mediate critical body functions. This research has led to innovative approaches to model fluid flow, mechanical forces, and oxygen gradients, which are all important developmental cues of the gut physiological system. A myriad of studies has demonstrated that gut-on-a-chip models reinforce a prolonged coculture of microbiota and human cells with genotypic and phenotypic responses that closely mimic the in vivo data. Accordingly, the excellent organ mimicry offered by gut-on-a-chips has fueled numerous investigations on the clinical and industrial applications of these devices in recent years. In this review, we outline various gut-on-a-chip designs, particularly focusing on different configurations used to coculture the microbiome and various human intestinal cells. We then elaborate on different approaches that have been adopted to model key physiochemical stimuli and explore how these models have been beneficial to understanding gut pathophysiology and testing therapeutic interventions.
- 28 February 2023
- Published by AIP Publishing in APL Bioengineering
- Vol. 7 (1) , 011502
Top Cited PapersOpen AccessGut-on-a-chip models for dissecting the gut microbiology and physiology
Microfluidic technologies have been extensively investigated in recent years for developing organ-on-a-chip-devices as robust in vitro models aiming to recapitulate organ 3D topography and its physicochemical cues. Among these attempts, an important research front has focused on simulating the physiology of the gut, an organ with a distinct cellular composition featuring a plethora of microbial and human cells that mutually mediate critical body functions. This research has led to innovative approaches to model fluid flow, mechanical forces, and oxygen gradients, which are all important developmental cues of the gut physiological system. A myriad of studies has demonstrated that gut-on-a-chip models reinforce a prolonged coculture of microbiota and human cells with genotypic and phenotypic responses that closely mimic the in vivo data. Accordingly, the excellent organ mimicry offered by gut-on-a-chips has fueled numerous investigations on the clinical and industrial applications of these devices in recent years. In this review, we outline various gut-on-a-chip designs, particularly focusing on different configurations used to coculture the microbiome and various human intestinal cells. We then elaborate on different approaches that have been adopted to model key physiochemical stimuli and explore how these models have been beneficial to understanding gut pathophysiology and testing therapeutic interventions.
- 1 February 2021
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 67, 1-6
Engineering biology approaches for food and nutrient production by cyanobacteria
- 1 February 2021
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 67, 1-6
Engineering biology approaches for food and nutrient production by cyanobacteria
- Open Access
- 10 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Manually curated genome-scale reconstruction of the metabolic network of Bacillus megaterium DSM319
Bacillus megaterium is a microorganism widely used in industrial biotechnology for production of enzymes and recombinant proteins, as well as in bioleaching processes. Precise understanding of its metabolism is essential for designing engineering strategies to further optimize B. megaterium for biotechnology applications. Here, we present a genome-scale metabolic model for B. megaterium DSM319, iJA1121, which is a result of a metabolic network reconciliation process. The model includes 1709 reactions, 1349 metabolites, and 1121 genes. Based on multiple-genome alignments and available genome-scale metabolic models for other Bacillus species, we constructed a draft network using an automated approach followed by manual curation. The refinements were performed using a gap-filling process. Constraint-based modeling was used to scrutinize network features. Phenotyping assays were performed in order to validate the growth behavior of the model using different substrates. To verify the model accuracy, experimental data reported in the literature (growth behavior patterns, metabolite production capabilities, metabolic flux analysis using 13C glucose and formaldehyde inhibitory effect) were confronted with model predictions. This indicated a very good agreement between in silico results and experimental data. For example, our in silico study of fatty acid biosynthesis and lipid accumulation in B. megaterium highlighted the importance of adopting appropriate carbon sources for fermentation purposes. We conclude that the genome-scale metabolic model iJA1121 represents a useful tool for systems analysis and furthers our understanding of the metabolism of B. megaterium.
- 10 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Open AccessManually curated genome-scale reconstruction of the metabolic network of Bacillus megaterium DSM319
Bacillus megaterium is a microorganism widely used in industrial biotechnology for production of enzymes and recombinant proteins, as well as in bioleaching processes. Precise understanding of its metabolism is essential for designing engineering strategies to further optimize B. megaterium for biotechnology applications. Here, we present a genome-scale metabolic model for B. megaterium DSM319, iJA1121, which is a result of a metabolic network reconciliation process. The model includes 1709 reactions, 1349 metabolites, and 1121 genes. Based on multiple-genome alignments and available genome-scale metabolic models for other Bacillus species, we constructed a draft network using an automated approach followed by manual curation. The refinements were performed using a gap-filling process. Constraint-based modeling was used to scrutinize network features. Phenotyping assays were performed in order to validate the growth behavior of the model using different substrates. To verify the model accuracy, experimental data reported in the literature (growth behavior patterns, metabolite production capabilities, metabolic flux analysis using 13C glucose and formaldehyde inhibitory effect) were confronted with model predictions. This indicated a very good agreement between in silico results and experimental data. For example, our in silico study of fatty acid biosynthesis and lipid accumulation in B. megaterium highlighted the importance of adopting appropriate carbon sources for fermentation purposes. We conclude that the genome-scale metabolic model iJA1121 represents a useful tool for systems analysis and furthers our understanding of the metabolism of B. megaterium.